.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Novartis
Merck
QuintilesIMS
Baxter
McKinsey
Federal Trade Commission
Daiichi Sankyo
Boehringer Ingelheim

Generated: December 14, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: cyclobenzaprine hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-596-2828 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-596-28)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-596-1010 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-596-10)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-596-6060 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-596-60)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-596-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-596-30)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-596-9090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-596-90)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-596-1515 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-596-15)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-810-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-810-30)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-810-9090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-810-90)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDASTAT RX USA LLC16590-810-6060 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-810-60)
Teva Pharms IntlAMRIXcyclobenzaprine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021777NDARebel Distributors Corp.21695-723-1414 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (21695-723-14)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Merck
McKesson
Medtronic
Federal Trade Commission
Healthtrust
Fish and Richardson
McKinsey
Chubb
Mallinckrodt

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot